Lazard Asset Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-56
| Closed | – | – | 2545 |
|
|
2025
Q1 | $0 | Sell |
56
-6,308
| -99% | – | ﹤0.01% | 2591 |
|
|
2024
Q4 | $67K | Buy |
+6,364
| New | +$67K | ﹤0.01% | 1918 |
|
|
2024
Q1 | – | Sell |
-354
| Closed | -$5K | – | 2395 |
|
|
2023
Q4 | $5K | Sell |
354
-2,957
| -89% | -$41.8K | ﹤0.01% | 2122 |
|
|
2023
Q3 | $46K | Buy |
+3,311
| New | +$46K | ﹤0.01% | 1886 |
|
|
2023
Q2 | – | Sell |
-3,111
| Closed | -$28K | – | 2562 |
|
|
2023
Q1 | $28K | Hold |
3,111
| – | – | ﹤0.01% | 1970 |
|
|
2022
Q4 | $27K | Buy |
+3,111
| New | +$27K | ﹤0.01% | 2076 |
|
|
2021
Q4 | – | Sell |
-3,281
| Closed | -$55K | – | 2475 |
|
|
2021
Q3 | $55K | Buy |
+3,281
| New | +$55K | ﹤0.01% | 1640 |
|